The administration of 62.5 mg/kg/day of SDZ 200–110, a calcium channel blocker, for 2 years increased the incidence of Leydig cell tumors while decreasing pituitary tumors in Sprague-Dawley rats. Lower doses did not change the incidence of these tumors. No other endocrine tumors were seen in rats or mice of either sex. A single gavage dose of 62.5 mg/kg/day decreased serum testosterone levels by 90% 4 hr after dosing. In vitro testosterone production by Leydig cells from these animals was minimally decreased, which suggests that a direct inhibition of steroid synthesis was removed during cell isolation. Dietary administration of the drug for 10 weeks did not significantly alter levels of serum hormones or testicular luteinizing hormone (LH) and gonadotropin-releasing hormone (GnRH) receptors, although a significant elevation of testicular testosterone levels was seen. Increased serum levels of LH and follicle-stimulating hormone (FSH) were seen after 52 and 66 weeks, respectively, of dietary feeding of 62.5 mg/kg/day. The increase in serum LH was observed to week 104, while FSH levels returned to control levels by week 94. No effect on gonadotropin receptors was seen at the 6.25 mg/kg/day dosage. The age-related increase in serum prolactin was markedly reduced by 62.5 mg/kg/day of SDZ 200–110 in weeks 66 to 104 and to a lesser extent at the 6.25 mg/kg/day dosage. Testicular LH receptors were decreased by the high dose in animals sacrificed after 90–104 weeks. In conclusion, SDZ 200–110 increases the incidence of Leydig cell tumors by elevating levels of serum gonadotropins. The suggested mechanism for this increase in gonadotropins is a result of the effects of SDZ 200–110 on serum hormones and testicular LH receptors. The drug was judged not to pose a risk to humans since no change in gonadotropin levels was observed after chronic treatment.
References
1.
1. Van Ryzin, R. J. (1988). Unpublished observations, Sandoz Research Institute, East Hanover, Nj.
2.
2. Christensen, A. K., and Peacock, K. C. (1980). Increase in Leydig cell number in the testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol. Reprod.22, 383–391.
3.
3. Clayton, R. N., Katikineni, M., Chan, V., Dufau, M. L., and Catt, K. J. (1980). Direct inhibition of testicular function by gonadotropin-releasing hormone: Mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proc. Natl. Acad. Sci.77, 4459–4463.
4.
4. Clayton, R. N., and Huhtaniemi, I. T. (1982). Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature299, 56–59.
5.
5. Brown, J. L., and Reeves, J. J. (1983). Absence of leuteinizing hormone releasing hormone receptors in ovine, bovine and porcine ovaries. Biol. Reprod.29, 1179–1182.
6.
6. Dufau, M. L., Pock, R., Newbauer, A., and Catt, K. J. (1976) In vitro bioassay of Lh in human serum: The rat interstitial cell testosterone (Rict) assay. J. Clin. Endocrinol. Metab.42, 958–976.
7.
7. Klinefelter, G. R., Hall, R. F., and Ewing, L. L. (1987). Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol. Reprod.36, 769–783.
8.
8. Roberts, S. A. (1988). Unpublished observations, Sandoz Research Institute, East Hanover, Nj.
9.
9. Gay, V. L., and Kerlan, J. T. (1978). Serum Lh and Fsh following passive immunization against circulating testosterone in the intact male rat and in orchidectomized rats bearing subcutaneous silastic implants of testosterone. Arch. Androl.1, 257–266.
10.
10. Russfield, A. (1967). Pathology of the endocrine glands, ovary and testis of rats and mice. In: Pathology of Laboratory Rats and Mice. E. Cotchin and F. J. C. Roe (eds.). Phildelphia: F. A. Davis, pp. 391–467.
11.
11. Mostofi, F., and Bresler, V. (1973). Tumors of the testis. In: Pathology of Tumors in Laboratory Animals, Volume 1—Tumors of the Rat. Part 2. V. Turusov (ed.). Lyon: Iarc, pp. 135–150.
12.
12. Furth, S., Nakane, P., and Pastells, J. (1973). Tumors of the pituitary. In: Pathology of Tumors in Laboratory Animals, Volume 1—Tumors of the Rat. Part 2. V. Turusov (ed.). Lyon: Iarc, pp. 201–238.
13.
13. King, N. (1978). The reproductive tract. In: Pathology of Laboratory Animals. Volume I. K. Bernerschke, F. M. Garner, and T. C. Jones (eds.). Berlin: Springer-Verlag, pp. 509–580.
14.
14. Altman, N. and Goodman, D. (1979). Neoplastic diseases. In: The Laboratory Rat, Volume I, Biology and Diseases. H. Baker, J. Lindsey, and S. Weisbroth (eds.). New York: Academic Press, pp. 334–377.
15.
15. Carlton, W., and Gries, C. (1983). The pituitary. In: Endocrine System. T. Jones, V. Mohr, and R. Hart (eds.). Berlin: Springer-Verlag, pp. 99–169.
16.
16. Krulich, L., Hefco, E., Illner, P., and Read, C. B. (1974). The effects of acute stress on the secretion of Lh, Fsh, prolactin and Gh in the normal male rat, with comments on their statistical evaluation. Neuroendocrinology16, 293–311.
17.
17. Mattheij, J. A. M. and Van Pykeren, T. A. (1977). Plasma prolactin in undisturbed cannulated male rats; effects of perphenazine, frequent sampling, stress and castration plus oestrone treatment. Acta Endocrinol.84, 51–61.
18.
18. Roberts, S., D'Elia, T., Fourney, P., and Stoll, R. (1989). The alteration of serum hormone levels by single and repeated ether administration. Toxicologist9, 275.
19.
19. Niswender, G. D., Midgley, A. R., Monroe, S. E., and Reickert, L. E. (1968). Radioimmunoassay for rat luteinizing hormone with anti-ovine Lh serum and ovine Lh-131I. Proc. Soc. Exp. Biol. Med.128, 807–811.
20.
20. Gay, V. L., Midgley, A. R., and Niswender, G. D. (1970). Patterns of gonadotropin secretion associated with ovulation. Fed. Proc.29, 1880–1887.
21.
21. Berndston, W. E., Pickett, B. W., and Nett, T. M. (1974). Reproductive physiology of the stallion. Iv. Seasonal changes in testosterone concentration of peripheral plasma. J. Reprod. Fertil.39, 115–118.
22.
22. Huhtaniemi, I. T., and Catt, K. J. (1983). Effect of gonadotropin-releasing hormone receptor blockage on rat testicular gonadotropin and lactogen receptors, steroidogenesis and responses to chronionic gonadotropin stimulation. Endocrinology116, 281–287.
23.
23. Wagner, T. O. F., Adams, T. E., and Nett, T. M. (1979). GnRh interaction with anterior pituitary. I. Determination of the affinity and number of receptors for GnRh in the ovine anterior pituitary. Biol. Reprod.20, 140–149.
24.
24. Tannenbaum, G. S. (1980). Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology107, 2117–2120.
25.
25. Huhtaniemi, I. T., Warren, D. W., and Catt, K. J. (1984). Functional maturation of rat testis Leydig cells. Ann. N. Y. Acad. Sci.438, 283–303.
26.
26. Ketelslegers, J. M., Hetzel, W. E., Sherins, R. J., and Catt, K. J. (1978). Developmental changes in testicular gonadotropin receptors: plasma gonadotropins and plasma testosterone in the rat. Endocrinology103, 212–222.
27.
27. Swerdloff, R. S., Walsh, P. C., Jacobs, H. S., and Odell, W. D. (1971). Serum Lh and Fsh during sexual maturation in the male rat: effect of castration and cryptorchidism. Endocrinology88, 120–128.
28.
28. Payne, A. H., Kelch, R. P., Murono, E. P., and Kerlan, J. T. (1977). Hypothalamic, pituitary and testicular function during sexual maturation of the male rat. J. Endocrinol.72, 17–26.
29.
29. Kerr, J. B., and Sharpe, R. M. (1985). Follicle stimulating hormone induction of Leydig cell maturation. Endocrinology116, 2592–2604.
30.
30. Hsueh, A. J. W., Dufau, M. L., and Catt, K. J. (1978). Direct inhibiting effect of estrogen on Leydig cell function of hypophysectomized rats. Endocrinology103, 1096–1102.
31.
31. Kerr, J. V. and Sharpe, R. M. (1985). Stimulatory effect of follicle stimulating hormone on rat Leydig cells. Cell Tissue Res.239, 405–415.
32.
32. Odell, W. D., Swerdloff, R. S., Jacobs, H. S., and Hescox, M. A. (1973). Fsh induction of sensitivity to Lh: One cause of sexual maturation in the male rat. Endocrinology92, 160–165.
33.
33. Brown, C. E., Warren, S., Chute, R. N., Ryan, K. J., and Todd. R. B. (1979). Hormonally induced tumors of the reproductive system of parabiosed male rats. Cancer Res.39, 3971–3976.
34.
34. Biskind, M. S. and Biskind, G. R. (1945). Tumor of rat testis produced by heterotransplantation of infantile testis to spleen of adult castrate. Proc. Soc. Exp. Biol. Med.59, 4–8.
35.
35. Twombly, G. H., Meisel, D., and Stout, A. P. (1949). Leydig cell tumors induced experimentally in the rat. Cancer2, 884–892.
36.
36. Kullander, S. (1960). On tumor information in gonadal and hypophyseal transplants into the anterior eye chambers of gonadectomized rats. Cancer Res.20, 1079–1082.
37.
37. Marko, M. (1987). Unpublished observations, Sandoz Ltd., Basle. Switzerland.
38.
38. Zipf, W. B., Payne, A. H., and Kelch, R. P. (1977). Prolactin, growth hormone, and luteinizing hormone in the maintenance of testicular luteinizing hormone receptors. Endocrinology103, 595–600.
39.
39. Baranao, J. L. S., Tesone, M.Calvo, J. C., Luthy, I. A., Gonzalez, S. I., Charreau, E. H., and Calandra, R. S. (1983). Prolactin effects on the prepubertal male rat. In: Recent Advances in Male Reproduction: Molecular Basis and Clinical Implications. R. D'Agata, M. B. Lipsett, R. Polosa, and H. J. Van der Molen (eds.). New York: Roman Press, pp. 305–312.
40.
40. Smith, M. S., and Bartke, A. J. (1987). Effects of hyperprolactinemia on the control of luteinizing hormone and follicle-stimulating hormone secretion in the male rate. Biol. Reprod.36, 138–147.
41.
41. Hodson, C. A., Simpkins, J. W., Pass, J. W., Aylsworth, C. F., Steger, R. W., and Meites, J. (1980). Effects of a prolactin secreting pituitary tumor on hypothalamic, gonadotropic and testicular function in male rats. Neuroendocrinology30, 7–10.
42.
42. Bartke, A., Sweeney. C. A., Johnson, L., Castracane, V. D., and Doherty, P. C. (1985). Hyperprolactinemia inhibits development of Leydig cell tumors in aging Fischer rats. Exp. Aging Res.11, 123–128.
43.
43. Cohen, M. and Gonasun, L. (1988). Unpublished observations, Sandoz Research Institute, East Hanover, Nj.
44.
44. Lee, C., Jesick, C., Salkowski, W., Uke, E. and J. T. Grayhack (1981). Testicular neoplasia: clinical and experimental. In: Hormone Related Tumors. H. Nagasawa and K. Abe (eds.). Berlin, New York: Japan Scientific Societies Press, pp. 289–311.
45.
45. Oshima, H., and Troen, P. (1981). Disorders of sexual differentiation and development. In: Endocrinology and Metabolism. P. Felig, J. D. Baxter, A. E. Broadus, and L. A. Froham (eds.). New York: McGraw-Hill, pp. 725–761.
46.
46. Turek, F. W. and Desjardins, C. (1979). Development of Leydig cell tumors and onset of changes in the reproduction and endocrine systems of aging F344 rats. J. Natl. Cancer Inst.63, 969–975.
47.
47. Physicians Desk Reference (1988). Volume 42. Oradell, N. J.: Medical Economics Co., p. 2032.
48.
48. Physicians Desk Reference (1988). Volume 42. Oradell, N. J.: Medical Economics Co., p. 859.
49.
49. Physicians Desk Reference (1988). Volume 42. Oradell, N. J.: Medical Economics Co., p. 1570.
50.
50. Physicians Desk Reference (1988). Volume 42. Oradell, N. J.: Medical Economics Co., p. 990.
51.
51. Jaffe, J. H. (1988). Unpublished observations, Sandoz Research Institute, East Hanover, Nj.
